Fortress Biotech, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
57.13 |
71.71 |
114.56 |
198.80 |
| Przychód Δ r/r |
0.00% |
25.52% |
59.75% |
73.53% |
| Przychód (min) |
55.19 |
57.18 |
93.59 |
160.82 |
| Przychód (max) |
58.54 |
86.25 |
135.53 |
236.78 |
| EBITDA (średnia) |
-57.13 |
-71.71 |
-114.56 |
-198.80 |
| EBIT (średnia) |
-57.13 |
-71.71 |
-114.56 |
-198.80 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-72.88 |
-29.10 |
-17.15 |
-9.56 |
| Zysk netto % |
-127.57% |
-40.58% |
-14.97% |
-4.81% |
| EPS (średnia) |
-3.51 |
-1.40 |
-0.82 |
-0.46 |
| Liczba analityków (Przychody) |
3 |
2 |
2 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
1 |
1 |
| symbol |
FBIOP |
FBIOP |
FBIOP |
FBIOP |